Redesigning Delivery of Opioids to Optimize Pain Management, Improve Outcomes, and Contain Costs

Authors


  • Conflict of Interest/Disclosure: Dr. Turk has received grant support and/or consulting fees from Eli Lilly, Endo, Feering, Galderma, OrthoMcNeil-Janssen, Pfizer, Philips Respironics, the National Institutes of Health, and the United States Food and Drug Administration.

Reprint requests to: Dennis C. Turk, PhD, University of Washington Medical Center, Box 356540, Seattle, WA 98195-6540, USA. Tel: 206-616-2626; Fax: 206-543-2958; E-mail: turkdc@uw.edu.

Abstract

Introduction

Chronic pain is a public health concern, and in the last decade, there has been a dramatic increase in the use and abuse of prescription opioids for chronic non-cancer pain.

Methods

We present an overview of a five-component model of pain management implemented at the University of Washington Division of Pain Medicine designed to facilitate recent state guidelines to reduce the risks associated with long-term use of prescription opioids.

Results

Central to the model described are guidelines for best clinical practice, a collaborative care approach, telehealth solutions, comprehensive prescription-monitoring, and measurement-based care.

Discussion

The model presented is a patient-centered, efficient, and cost-effective approach to the management of chronic pain.

Ancillary